| P50 | author | Eduard Vieta | Q20090640 |
| | Ferran Torres | Q43088594 |
| | Jose Sanchez-Moreno | Q47810763 |
| P2093 | author name string | Nuria Cruz | |
| | Marc Valentà | |
| | Jose Manuel Goikolea | |
| P2860 | cites work | Characterizing barriers, challenges and unmet needs in the management of bipolar disorder | Q81512737 |
| | Practice guideline for the treatment of patients with bipolar disorder (revision) | Q95789383 |
| | Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies | Q31127921 |
| | The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease | Q32112799 |
| | Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). | Q34000973 |
| | Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania | Q34531273 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. | Q34588960 |
| | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression | Q35024109 |
| | Bipolar depression: phenomenological overview and clinical characteristics | Q35947340 |
| | Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder | Q36162402 |
| | Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials | Q36466463 |
| | Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications | Q36550498 |
| | Role of aripiprazole in treating mood disorders | Q36688973 |
| | Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials | Q36778511 |
| | Diagnostic guidelines for bipolar depression: a probabilistic approach | Q37058580 |
| | A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania | Q40210795 |
| | Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 |
| | Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 |
| | Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 |
| | Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial | Q44299951 |
| | Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study | Q44874572 |
| | Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 |
| | Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol | Q45168624 |
| | Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). | Q46519540 |
| | A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 |
| | Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial | Q46596821 |
| | Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study | Q46669710 |
| | Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 |
| | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 |
| | Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes | Q46775574 |
| | Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies | Q46801835 |
| | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 |
| | Clinical correlates of first-episode polarity in bipolar disorder. | Q50920723 |
| | Clinical and therapeutic implications of predominant polarity in bipolar disorder. | Q51918274 |
| P433 | issue | 1 | |
| P921 | main subject | placebo | Q269829 |
| | meta-analysis | Q815382 |
| | bipolar depression | Q56014658 |
| P304 | page(s) | 5-14 | |
| P577 | publication date | 2009-07-29 | |
| P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
| P1476 | title | Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis | |
| P478 | volume | 13 | |